Empowered Patient Podcast

Karen Jagoda
  • 4.9 (18)
  • Medicine
  • Updated Daily

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

  1. 2h ago ·  Bonus

    Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com TRANSCRIPT

    Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel explains, "Hearing loss can happen really gradually, and so oftentimes it can go unnoticed. What we do is we like to educate people on the early signs of hearing loss, such as asking others to repeat themselves, turning the television up, or family members noticing it before them. And then when it comes to the actual hearing test, we do a full comprehensive audiological evaluation. In that audiological evaluation, we sometimes see signs of other health issues. We do make referrals to other specialists such as ear, nose, and throat physicians if we're seeing that something else might be happening in the health of that person."   "I honestly feel like one of the most exciting developments in hearing healthcare is our growing understanding of the hearing-brain connection. We really don't hear with our ears. We really hear with our brain. Our ears are collecting the sound, but our brain is really giving that sound meaning. So what can happen if we don't treat hearing loss and it goes untreated is something called auditory deprivation, which essentially just means we're depriving the brain of the sound that it's looking for. And what happens is the brain then has to work a little harder and devote extra resources to decoding that speech and sound. And that extra effort is what can lead to some strain on other cognitive functions such as memory. So we see that that strain, because we hear with our brain, can lead to some of those other cognitive functions declining." #HearingCom #HearingHealth #Teleaudiology #Audiology #HearingAids #DigitalHealth #CognitiveHealth #PatientCare #HearingCareInnovation #HearingWellness hear.com Listen to the podcast here

  2. 3h ago

    Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com

    Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel explains, "Hearing loss can happen really gradually, and so oftentimes it can go unnoticed. What we do is we like to educate people on the early signs of hearing loss, such as asking others to repeat themselves, turning the television up, or family members noticing it before them. And then when it comes to the actual hearing test, we do a full comprehensive audiological evaluation. In that audiological evaluation, we sometimes see signs of other health issues. We do make referrals to other specialists such as ear, nose, and throat physicians if we're seeing that something else might be happening in the health of that person."   "I honestly feel like one of the most exciting developments in hearing healthcare is our growing understanding of the hearing-brain connection. We really don't hear with our ears. We really hear with our brain. Our ears are collecting the sound, but our brain is really giving that sound meaning. So what can happen if we don't treat hearing loss and it goes untreated is something called auditory deprivation, which essentially just means we're depriving the brain of the sound that it's looking for. And what happens is the brain then has to work a little harder and devote extra resources to decoding that speech and sound. And that extra effort is what can lead to some strain on other cognitive functions such as memory. So we see that that strain, because we hear with our brain, can lead to some of those other cognitive functions declining." #HearingCom #HearingHealth #Teleaudiology #Audiology #HearingAids #DigitalHealth #CognitiveHealth #PatientCare #HearingCareInnovation #HearingWellness hear.com Download the transcript here

  3. 1d ago ·  Bonus

    Parkinson's Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs TRANSCRIPT

    Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to optimize treatment strategies and accelerate development of therapies. Amy explains, "Rune Labs has been around for about seven years. We have consumer-facing and patient-facing technologies, with a core product called StrivePD. StrivePD helps patients with Parkinson's disease better manage their symptoms by passively tracking their movements, ingesting data that comes in naturally through HealthKit, and asking those patients questions so they can go back and forth with the app, better understand their disease, and provide actionable insights against it."   "If you think about the way that neurodegenerative diseases are treated, and Parkinson's is one of the best examples, historically, the disease has been treated as a moment-in-time disease. You see a clinician every six months if you're lucky, and that clinician is observing you in the moment. They're asking you about how you have been, and then they're applying a fairly well-researched, precise treatment to that very subjective point in time. What Rune Labs is out to solve is twofold. One, we are bringing objective longitudinal data to that discussion. So rather than rely on that point in time, you as a patient can now bring a report in that shows what the last six months have looked like, in fact, as your movements go throughout the day. And so your clinician can see tremor, dyskinesia, can see how it changes with time, and can see how it changes with your medication schedule." #RuneLabs #ParkinsonsDisease #DigitalHealth #BrainData #PrecisionMedicine #Neurology #AIinHealthcare #StrivePD runelabs.io Listen to the podcast here

  4. 1d ago

    Parkinson's Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs

    Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to optimize treatment strategies and accelerate development of therapies. Amy explains, "Rune Labs has been around for about seven years. We have consumer-facing and patient-facing technologies, with a core product called StrivePD. StrivePD helps patients with Parkinson's disease better manage their symptoms by passively tracking their movements, ingesting data that comes in naturally through HealthKit, and asking those patients questions so they can go back and forth with the app, better understand their disease, and provide actionable insights against it."   "If you think about the way that neurodegenerative diseases are treated, and Parkinson's is one of the best examples, historically, the disease has been treated as a moment-in-time disease. You see a clinician every six months if you're lucky, and that clinician is observing you in the moment. They're asking you about how you have been, and then they're applying a fairly well-researched, precise treatment to that very subjective point in time. What Rune Labs is out to solve is twofold. One, we are bringing objective longitudinal data to that discussion. So rather than rely on that point in time, you as a patient can now bring a report in that shows what the last six months have looked like, in fact, as your movements go throughout the day. And so your clinician can see tremor, dyskinesia, can see how it changes with time, and can see how it changes with your medication schedule." #RuneLabs #ParkinsonsDisease #DigitalHealth #BrainData #PrecisionMedicine #Neurology #AIinHealthcare #StrivePD runelabs.io Download the transcript here

  5. 1d ago ·  Bonus

    Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI TRANSCRIPT

    Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions and establishing long-lasting immune tolerance. Sid explains, "Today, millions of people suffer from food allergies in the US and worldwide. And that's a spectrum from just the mild symptoms that cause discomfort to the really severe kind, which can lead to life-threatening issues. And for us as a company, that's where we focus and where the biggest need is to come up with new treatments that can help prevent these life-threatening events from happening."   "A lot of it is symptom management, and EpiPens are a staple. Everyone who has had a severe reaction or may have one has to carry one around that can help prevent you from having the cardiac and lung issues that cause death. But there's no real treatment that can prevent someone from having these severe reactions. And this is where we're focused: treating the root cause of these severe reactions in the hope that we can develop a treatment that can prevent these terrible reactions from happening." "The triggers can be wide-ranging, from many different food products such as peanuts or seafood or milk. It could be anything really that can sensitize one to have a reaction. And even beyond food, all other types of allergens like bee stings can cause a reaction. We know the cell type that is central to these reactions, and it's a cell type called a mast cell."  #AllerGeneAI #MastCells #AllergicReaction #SevereAllergy #FoodAllergy #AllergyGeneTherapy #GeneTherapy allergene.ai Listen to the podcast here

  6. 1d ago

    Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI

    Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions and establishing long-lasting immune tolerance. Sid explains, "Today, millions of people suffer from food allergies in the US and worldwide. And that's a spectrum from just the mild symptoms that cause discomfort to the really severe kind, which can lead to life-threatening issues. And for us as a company, that's where we focus and where the biggest need is to come up with new treatments that can help prevent these life-threatening events from happening."   "A lot of it is symptom management, and EpiPens are a staple. Everyone who has had a severe reaction or may have one has to carry one around that can help prevent you from having the cardiac and lung issues that cause death. But there's no real treatment that can prevent someone from having these severe reactions. And this is where we're focused: treating the root cause of these severe reactions in the hope that we can develop a treatment that can prevent these terrible reactions from happening." "The triggers can be wide-ranging, from many different food products such as peanuts or seafood or milk. It could be anything really that can sensitize one to have a reaction. And even beyond food, all other types of allergens like bee stings can cause a reaction. We know the cell type that is central to these reactions, and it's a cell type called a mast cell."  #AllerGeneAI #MastCells #AllergicReaction #SevereAllergy #FoodAllergy #AllergyGeneTherapy #GeneTherapy allergene.ai Download the transcript here

  7. 2d ago ·  Bonus

    Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health TRANSCRIPT

    Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce emergency room revisits and hospital readmissions.  David explains, "Dimer Health is a health tech company. It's a medical practice deliberately built to better serve patients after any post-acute care event. And what I mean by that is patients go to the emergency room and are discharged, patients are admitted to the hospital and are discharged, maybe they have surgery. And it's in those first 1 to 3 days after that when the trajectory of their recovery is really determined. As an emergency room physician, I see a lot of those complications that come in. A couple of our founders were also emergency room providers, and so we wanted to be deliberate about building a medical practice, a virtual care medical practice that fits right into that window to prevent those patients from coming back to the hospital." "And I think a good example of that is a very realistic scenario: a patient has joint replacement surgery, and it's a couple of days later. Their pain medications are changing. Maybe they're transitioning to different types of pain medications, or they're just starting to utilize their pain medications. They're adjusting to new mobility issues. Maybe they're learning different kinds of injections or blood thinners. They're not sleeping well. Families are trying to help, and there are just changes to their home life that occur because of the procedure that happened. And when you're outside the four walls of the hospital, it's sometimes difficult to understand what's normal post-op healing and what's more concerning than that." #DimerHealth #JointReplacement, #PostAcuteCare, #PatientSafety #HospitalReadmissions, #PostDischargeCare, #SurgicalRecovery dimerhealth.com Listen to the podcast here

  8. 2d ago

    Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health

    Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce emergency room revisits and hospital readmissions.  David explains, "Dimer Health is a health tech company. It's a medical practice deliberately built to better serve patients after any post-acute care event. And what I mean by that is patients go to the emergency room and are discharged, patients are admitted to the hospital and are discharged, maybe they have surgery. And it's in those first 1 to 3 days after that when the trajectory of their recovery is really determined. As an emergency room physician, I see a lot of those complications that come in. A couple of our founders were also emergency room providers, and so we wanted to be deliberate about building a medical practice, a virtual care medical practice that fits right into that window to prevent those patients from coming back to the hospital." "And I think a good example of that is a very realistic scenario: a patient has joint replacement surgery, and it's a couple of days later. Their pain medications are changing. Maybe they're transitioning to different types of pain medications, or they're just starting to utilize their pain medications. They're adjusting to new mobility issues. Maybe they're learning different kinds of injections or blood thinners. They're not sleeping well. Families are trying to help, and there are just changes to their home life that occur because of the procedure that happened. And when you're outside the four walls of the hospital, it's sometimes difficult to understand what's normal post-op healing and what's more concerning than that." #DimerHealth #JointReplacement, #PostAcuteCare, #PatientSafety #HospitalReadmissions, #PostDischargeCare, #SurgicalRecovery dimerhealth.com Download the transcript here

See All (2K)

4.9
out of 5
18 Ratings

About

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

Information